These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

734 related items for PubMed ID: 25295718

  • 1. Testing the therapeutic equivalence of novel oral anticoagulants for thromboprophylaxis in orthopedic surgery and for prevention of stroke in atrial fibrillation.
    Messori A, Fadda V, Maratea D, Trippoli S, Marinai C.
    Int J Clin Pharmacol Ther; 2015 Mar; 53(3):211-9. PubMed ID: 25295718
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Comparison of efficacy and safety of dabigatran, rivaroxaban and apixaban in patients with atrial fibrillation using network meta-analysis.
    Harenberg J, Marx S, Diener HC, Lip GY, Marder VJ, Wehling M, Weiss C.
    Int Angiol; 2012 Aug; 31(4):330-9. PubMed ID: 22801398
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Perioperative management of patients on new oral anticoagulants.
    Lai A, Davidson N, Galloway SW, Thachil J.
    Br J Surg; 2014 Jun; 101(7):742-9. PubMed ID: 24777590
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Net clinical benefit of new oral anticoagulants (dabigatran, rivaroxaban, apixaban) versus no treatment in a 'real world' atrial fibrillation population: a modelling analysis based on a nationwide cohort study.
    Banerjee A, Lane DA, Torp-Pedersen C, Lip GY.
    Thromb Haemost; 2012 Mar; 107(3):584-9. PubMed ID: 22186961
    [Abstract] [Full Text] [Related]

  • 9. Rivaroxaban: an oral factor Xa inhibitor.
    Thomas TF, Ganetsky V, Spinler SA.
    Clin Ther; 2013 Jan; 35(1):4-27. PubMed ID: 23328267
    [Abstract] [Full Text] [Related]

  • 10. [New oral anticoagulants - sunset for warfarin in therapy of atrial fibrillation].
    Koziński M, Obońska K, Kubica A, Navarese EP, Kubica J.
    Kardiol Pol; 2012 Jan; 70(10):1053-60. PubMed ID: 23080100
    [No Abstract] [Full Text] [Related]

  • 11. Novel oral anticoagulants--key messages for the angiologist.
    Haas S, Spannagl M, Schellong SM.
    Vasa; 2012 May; 41(3):177-91. PubMed ID: 22565619
    [Abstract] [Full Text] [Related]

  • 12. Edoxaban in the evolving scenario of non vitamin K antagonist oral anticoagulants imputed placebo analysis and multiple treatment comparisons.
    Verdecchia P, Angeli F, Lip GY, Reboldi G.
    PLoS One; 2014 May; 9(6):e100478. PubMed ID: 24955573
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Phase III studies on novel oral anticoagulants for stroke prevention in atrial fibrillation: a look beyond the excellent results.
    Pengo V, Crippa L, Falanga A, Finazzi G, Marongiu F, Moia M, Palareti G, Poli D, Testa S, Tiraferri E, Tosetto A, Tripodi A, Siragusa S, Manotti C.
    J Thromb Haemost; 2012 Oct; 10(10):1979-87. PubMed ID: 22827490
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Target-specific oral anticoagulants: practice issues for the clinician.
    Plitt A, Giugliano RP.
    Hosp Pract (1995); 2014 Aug; 42(3):48-61. PubMed ID: 25255406
    [Abstract] [Full Text] [Related]

  • 18. Approach to the new oral anticoagulants in family practice: part 2: addressing frequently asked questions.
    Douketis J, Bell AD, Eikelboom J, Liew A.
    Can Fam Physician; 2014 Nov; 60(11):997-1001. PubMed ID: 25392439
    [Abstract] [Full Text] [Related]

  • 19. Editor's Choice - efficacy and safety of the new oral anticoagulants dabigatran, rivaroxaban, apixaban, and edoxaban in the treatment and secondary prevention of venous thromboembolism: a systematic review and meta-analysis of phase III trials.
    Kakkos SK, Kirkilesis GI, Tsolakis IA.
    Eur J Vasc Endovasc Surg; 2014 Nov; 48(5):565-75. PubMed ID: 24951377
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.